证券代码：001378 证券简称：德冠新材 公告编号：2024-035 广东德冠薄膜新材料股份有限公司 关于部分首次公开发行前已发行股份及战略配售股份 上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次解除限售的股份为广东德冠薄膜新材料股份有限公司（以下简称"公 司"）部分首次公开发行前已发行股份及首次公开发行战略配售股份。 2、本次申请解除限售股东户数共计 58 户，解除限售股份数量为 32,822,748 股，占公司总股本的比例为 24.62%，限售期为公司首次公开发行股票并上市之 日起 12 个月。其中，首次公开发行前已发行股份申请解除股份限售的股东户数 为 57 户，申请解除限售的股份数量为 31,716,372 股，占公司总股本的比例为 23.79%；首次公开发行战略配售股份申请解除股份限售的股东户数为 1 户，申请 解除限售的股份数量为 1,106,376 股，占公司总股本的比例为 0.83%。 3、本次解除限售的股份上市流通日期为 2024 年 10 月 30 日（星期三）。 一、首次公开发行前已发行股份概 ...

招商证券股份有限公司 关于广东德冠薄膜新材料股份有限公司 部分首次公开发行前已发行股份及战略配售股份 上市流通的核查意见 招商证券股份有限公司（以下简称"招商证券"或"保荐机构"）作为广东德冠 薄膜新材料股份有限公司（以下简称"德冠新材"或"公司"）首次公开发行股票并 上市及持续督导的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所股票上市规则》及《深圳证券交易所上市公司自律监管指引第 1 号—— 主板上市公司规范运作》等有关规定，对德冠新材部分首次公开发行前已发行股 份及首次公开发行战略配售股份进行了审慎核查，具体情况如下： 一、首次公开发行前已发行股份概况 经中国证券监督管理委员会《关于同意广东德冠薄膜新材料股份有限公司首 次公开发行股票注册的批复》（证监许可〔2023〕1717 号）同意注册，公司首次 公开发行人民币普通股（A 股）3,333.36 万股，并于 2023 年 10 月 30 日在深圳 证券交易所主板上市交易。 首次公开发行股票前公司总股本为 100,000,000 股，首次公开发行股票完成 后公司总股本为 133,333,600 股，其中有流通限制或限售安排的股份数量为 ...

证券代码：001378 证券简称：德冠新材 公告编号：2024-034 广东德冠薄膜新材料股份有限公司 关于参加广东辖区 2024 年投资者网上集体接待日活动的公 告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，广东德冠薄膜新材料股份有限公司（以 下简称"公司"）将参加由广东证监局、广东上市公司协会联合举办的"坚定信 心 携手共进 助力上市公司提升投资价值——2024 广东辖区上市公司投资者关 系管理月活动投资者集体接待日"，现将相关事项公告如下： 本次投资者网上集体接待日活动将采用网络远程的方式举行，投资者可登 录"全景路演"网站（http://rs.p5w.net）参与本次互动交流，活动时间为 2024 年 9 月 12 日（周四）15:30-16:30。届时公司董事和高管将在线就 2024 年半年度业 绩、公司治理、发展战略、经营状况等投资者关心的问题，与投资者进行沟通与 交流，欢迎广大投资者踊跃参与！ 特此公告。 广东德冠薄膜新材料股份有限公司董事会 2024 年 9 月 10 日 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集 资金管理和使用的监管要求》《深圳证券交易所上市公司自律监管指引第 1 号— —主板上市公司规范运作》等相关规定，广东德冠薄膜新材料股份有限公司（以 下简称"公司"）就 2024 年半年度募集资金的存放与使用情况专项说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 证券代码：001378 证券简称：德冠新材 公告编号：2024-030 广东德冠薄膜新材料股份有限公司 2024 年半年度募集资金存放与使用情况的专项报告 经深圳证券交易所上市审核委员会 2023 年第 31 次会议审议通过和中国证 券监督管理委员会《关于同意广东德冠薄膜新材料股份有限公司首次公开发行股 票注册的批复》（证监许可〔2023〕1717 号）同意注册，公司首次向社会公众公 开发行人民币普通股（A 股）33,333,600.00 股，每股面值 1.00 元，每股发行价格 31.68 元，募集资金总额为人民币 1,056,008,448.00 元，扣除承 ...

证券代码：001378 证券简称：德冠新材 公告编号：2024-031 广东德冠薄膜新材料股份有限公司 关于使用银行承兑汇票及信用证支付募投项目款项并以募 集资金等额置换的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 广东德冠薄膜新材料股份有限公司（以下简称"公司"）于 2024 年 8 月 26 日召开了第五届董事会第四次会议、第五届监事会第四次会议，审议通过了《关 于使用银行承兑汇票及信用证支付募投项目款项并以募集资金等额置换的议案》， 同意公司在募投项目实施期间，根据实际情况使用银行承兑汇票及信用证支付募 投项目款项，并定期从募集资金专项账户中等额置换转入公司一般账户。具体情 况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意广东德冠薄膜新材料股份有限公司首 次公开发行股票注册的批复》（证监许可〔2023〕1717 号）同意注册，公司首次 公开发行人民币普通股（A 股）3,333.36 万股，每股发行价格为人民币 31.68 元， 本次发行募集资金总额为 1,056,008,448.00 元，扣除不含税发行费用 104,246,3 ...

广东德冠薄膜新材料股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：001378 证券简称：德冠新材 公告编号：2024-033 一、对外担保情况概述 公司分别于 2024 年 4 月 23 日、2024 年 5 月 15 日召开了第五届董事会第三 次会议和 2023 年年度股东大会，审议通过了《关于公司及子公司 2024 年度向银 行申请授信额度及担保额度预计的议案》，同意公司及全资子公司为合并报表范 围内的全资子公司广东德冠包装材料有限公司（以下简称"德冠包装"）、德冠新 材料（香港）有限公司、广东顺德德冠艺云科技有限公司向银行等金融机构融资 或其他业务提供担保，担保总额度不超过人民币 252,850 万元, 其中：公司为全 资子公司德冠包装提供的担保额度为 241,850 万元。担保额度有效期限自 2023 年年度股东大会审议通过之日起 12 个月内有效。具体内容详见公司于 2024 年 4 月 25 日在巨潮资讯网上披露的《关于公司及子公司 2024 年度向银行申请授信额 度及提供担保额度预计的 ...

证券代码：001378 证券简称：德冠新材 公告编号：2024-028 广东德冠薄膜新材料股份有限公司 第五届董事会第四次会议决议公告 （二）审议通过《关于〈2024 年半年度募集资金存放与使用情况的专项报 告〉的议案》 具体内容详见公司同日披露在巨潮资讯网（www.cninfo.com.cn）上的《2024 年半年度募集资金存放与使用情况的专项报告》。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 广东德冠薄膜新材料股份有限公司（以下简称"公司"）第五届董事会第四 次会议于 2024 年 8 月 26 日在公司三楼会议室以现场结合通讯的方式召开。会议 通知于 2024 年 8 月 16 日通过通讯方式发出。本次会议应出席董事 9 人，实际出 席董事 9 人。会议由董事长罗维满主持，公司监事和高级管理人员列席了会议。 本次会议的召开符合国家有关法律、法规和《公司章程》的规定。 二、董事会会议审议情况 本次会议审议并通过了以下议案： （一）审议通过《关于公司 2024 年半年度报告及摘要的议案》 具体内容详见公司同日披露在巨潮资讯网（w ...

| 非经营性资金占用 | 资金占用方名称 | 占用方与上 市公司的关 | 上市公司核 算的会计科 | 2024 年期初 占用资金余 | 2024 | 年半年度占 用资金累计发生 | 2024 占用资金的利 | 年半年度 | 2024 年半年度 偿还资金累计 | 2024 30 | 年 6 月 日占用资 | 占用形 | 占用性 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | | | | 成原因 | 质 | | | | 联关系 | 目 | 额 | | 金额（不含利息） | | 息（如有） | 发生金额 | | 金余额 | | | | 控股股东、实际控制人及其 | | | | | | | | | | | | | | | 附属企业 | | | | | | | | | | | | | | | 小计 | | | | | | | | | | | | | | | 前控股股东、实际控制人及 | | | | | | | | | | | | | | | 其附属企业 ...

证券代码：001378 证券简称：德冠新材 公告编号：2024-029 具体内容详见公司同日披露在巨潮资讯网（www.cninfo.com.cn）上的 《2024 年半年度报告》和《2024 年半年度报告摘要》。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 广东德冠薄膜新材料股份有限公司 第五届监事会第四次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 广东德冠薄膜新材料股份有限公司（以下简称"公司"）第五届监事会第 四次会议于 2024年 8月 26日在公司会议室以现场会议的方式召开，会议通知于 2024 年 8 月 16 日通过通讯方式发出。本次会议应出席监事 3 人，实际出席监事 3人。会议由监事会主席杨展彪主持。董事会秘书王韶峰列席会议。本次会议的 召开符合国家有关法律、法规和《公司章程》的规定。 二、监事会会议审议情况 本次会议审议并通过了以下议案： （一）审议通过《关于公司 2024 年半年度报告及摘要的议案》 （二）审议通过《关于〈2024 年半年度募集资金存放与使用情况的专项 报告〉的议案》 具体 ...

Financial Performance - The company reported no cash dividends, stock bonuses, or capital reserve transfers for the fiscal year[1]. - The financial report was confirmed as true, accurate, and complete by the company's management, including the legal representative and accounting head[1]. - The company's operating revenue for the first half of 2024 was ¥755,674,696.35, representing a 40.20% increase compared to ¥538,998,831.02 in the same period last year[10]. - Net profit attributable to shareholders decreased by 21.96% to ¥51,863,711.85 from ¥66,456,681.04 year-on-year[10]. - The net profit after deducting non-recurring gains and losses was ¥52,486,796.72, down 13.97% from ¥61,012,586.96 in the previous year[10]. - The company's cash flow from operating activities was ¥49,688,360.62, a decline of 27.92% compared to ¥68,935,194.38 in the same period last year[10]. - Total assets at the end of the reporting period were ¥2,240,146,626.76, down 9.28% from ¥2,469,172,220.15 at the end of the previous year[10]. - The average return on equity decreased to 2.73% from 7.87% year-on-year, a drop of 5.14 percentage points[10]. - The company reported a total non-recurring loss of ¥623,084.87, primarily due to other operating income and expenses[12]. - The company reported a significant decrease in net cash and cash equivalents, down 318.23% to -¥381,088,810.10 from -¥91,119,097.36, primarily due to loan repayments[49]. - The gross profit margin for the rubber and plastic products manufacturing segment was 14.03%, down from the previous year's margin, indicating increased costs relative to revenue[51]. Market and Industry Trends - The demand for BOPP films in China is expected to grow, with a projected total demand of 4.783 million tons by 2028, averaging a growth rate of 3.55%[14]. - The food and beverage industry, a major application area for functional BOPP films, reported a cumulative revenue growth of 5.0% in the first half of 2024, amounting to ¥10,441.30 billion[18]. - The packaging industry, which includes BOPP films, is experiencing stable growth, with the number of large enterprises reaching 10,632 and a total revenue of ¥11,539.06 billion in 2023[16]. - The retail sales of cosmetics in China grew by 1% in the first half of 2024, reaching CNY 216.8 billion, indicating significant potential for growth in the cosmetics market[21]. - The overall demand in downstream industries such as packaging, food and beverage, and consumer electronics is steadily recovering, although price factors remain weak[39]. Research and Development - The company holds 48 domestic invention patents and 59 utility model patents as of June 30, 2024, showcasing its strong R&D capabilities[28]. - The company has developed high-performance, environmentally friendly new materials, focusing on "functionalization, high-end, and environmental protection" as its innovation direction[27]. - The company is actively developing functional masterbatch materials and has achieved self-sufficiency in the production and sales of matte masterbatch[27]. - The company has established a professional R&D team with expertise in polymer chemistry, materials science, and engineering, enhancing its innovation capabilities[28]. - The company has made significant advancements in the application of BOPP films in the new energy battery sector, particularly for use in electric vehicle batteries[25]. - The company has established a core technology platform including hot melt adhesive technology and hollowing technology, with all technologies in mass production stage[40]. - The company emphasizes "functionalization, high-end, and environmental protection" as its innovation direction, focusing on high-performance and low-carbon new materials[40]. Operational Risks and Challenges - The company faced potential operational risks, which are detailed in the management discussion section of the report[1]. - The company has faced risks related to technological innovation, particularly in meeting the increasing demand for high-quality products[66]. - The company has identified risks associated with the fluctuation of raw material prices, particularly for polypropylene and additives, which significantly impact operating costs[72]. - The company has acknowledged the potential risks of project investment and the need for timely funding to ensure successful project implementation[71]. - The company is focused on expanding its upstream and downstream business, but faces risks if it cannot meet market demands and industry developments[70]. Environmental Compliance - The company has established reliable treatment measures for wastewater, waste gas, and solid waste, ensuring compliance with national and local environmental regulations[81]. - No significant environmental pollution incidents occurred during the reporting period, and all environmental treatment systems are operating normally without exceeding discharge standards[81]. - The company has implemented an emergency response plan for environmental incidents, which has been filed with the government[82]. - The company has constructed pollution prevention facilities as per environmental regulations and regularly pays environmental protection taxes[83]. - The company’s subsidiaries have obtained various environmental permits, including pollution discharge permits valid until 2029[77]. Corporate Governance - The company has no changes in its board of directors, supervisors, or senior management during the reporting period[74]. - The company has not implemented any employee stock ownership plans or other incentive measures during the reporting period[75]. - The annual general meeting held on May 15, 2024, had an investor participation rate of 67.77%[74]. - The company has not engaged in any related party transactions during the reporting period[89]. - The company has not conducted any asset or equity acquisitions or sales during the reporting period[90]. Financial Management - The company has established a competitive employee compensation system to protect employee rights[85]. - The company has not engaged in any securities or derivative investments during the reporting period[58][59]. - The company has not provided any guarantees to external parties, excluding subsidiaries[94]. - The company has not experienced any bankruptcy reorganization matters during the reporting period[86]. - The company has established long-term partnerships with various suppliers, optimizing procurement strategies to enhance cost control and reduce the impact of market price fluctuations[48]. Investment Activities - The total investment amount for the reporting period was ¥101,892,451.42, a decrease of 64.99% compared to ¥291,031,940.10 in the same period last year[57]. - The company has established a new production capacity of 58,200 tons per year with the completion of the "De Guan Zhongxing Technology Park" project, which is expected to enhance its manufacturing scale[46]. - The new construction project of the De Guan Zhongxing Technology Park has an investment commitment of ¥55,132.12 million, with ¥46,004.03 million invested, representing 83.44% of the planned investment[60]. - The functional film and functional mother material expansion project has an investment commitment of ¥21,100 million, with only ¥1,856.07 million utilized, achieving an investment progress of 8.80%[60]. Financial Reporting and Accounting - The financial report for the half-year period has not been audited[117]. - The company adheres to the accounting standards, ensuring that its financial statements reflect a true and complete picture of its financial status[148]. - The company has established significant accounting policies, including the treatment of business combinations and the measurement of assets and liabilities[153]. - The company follows a control-based approach for determining the scope of consolidated financial statements, which includes subsidiaries based on voting rights and contractual arrangements[154]. - The company recognizes goodwill when the acquisition cost exceeds the fair value of identifiable net assets acquired[156].